Literature DB >> 36247252

Prevalence and risk factors of Helicobacter pylori infection in Ningxia, China: comparison of two cross-sectional studies from 2017 and 2022.

Yan Zhou1, Yanhong Deng2, Yanjie You2, Xue Li2, Di Zhang3, Hailong Qi4, Ruichun Shi5, Li Yao2, Yuanyuan Tang2, Xiaofei Li2, Linke Ma2, Yanlin Li2, Jun Liu2, Yaning Feng2, Xianmei Chen2, Qian Hao2, Xuemei Li2, Yuzhen Li2, Min Niu2, Hengjun Gao6,7,8, Feihu Bai9,10, Shengjuan Hu2.   

Abstract

OBJECTIVES: Helicobacter pylori (H. pylori) infection causes a variety of intragastric and extragastric diseases. Despite its decreasing global prevalence, it remains a major public health problem in many developing countries. This study aimed to understand the prevalence of H. pylori infection and its risk factors in five cities of the Ningxia Hui Autonomous Region, an area with high incidence of gastric cancer.
METHODS: Cross-sectional studies were conducted in Ningxia from 2017 and 2022, to detect the prevalence of H. pylori using the 14C urea breath test. All participants completed a questionnaire that included demographics, personal habits, household economic characteristics, and previous health status. Multiple logistic regression analyses were used to identify independent factors for H. pylori infection.
RESULTS: Our findings demonstrated that the prevalence of H. pylori infection in Ningxia decreased significantly from 60.3% in 2017 to 43.6% in 2022, with an increase in public awareness rate from 35.9% in 2017 to 68.5% in 2022. The lowest infection rate was found in Zhongwei and highest in Guyuan. The prevalence of H. pylori infection was higher among Hui ethnicity, farmers, individuals living in rural areas, individuals with lower income, low education, and those who consumed less fruit. Gallbladder, respiratory, cardiovascular and autoimmune diseases were not associated with H. pylori infection.
CONCLUSIONS: The prevalence of H. pylori in Ningxia decreased in the past five years. Ethnicity, location, occupation, income, education, and consumption of fruits were independent risk factors for H. pylori infection in Ningxia. It was not associated with extra-gastric disease. AJTR
Copyright © 2022.

Entities:  

Keywords:  Helicobacter pylori; Ningxia; prevalence; risk factors

Year:  2022        PMID: 36247252      PMCID: PMC9556490     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  41 in total

Review 1.  Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis.

Authors:  Ben Wang; Zhi-Fa Lv; You-Hua Wang; Hui Wang; Xiao-Qun Liu; Yong Xie; Xiao-Jiang Zhou
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

2.  Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication.

Authors:  Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Ryugo Sato; Masahiro Uchida; Takashi Abe; Seiji Shiota; Yoshifumi Nakagawa; Kazuhiro Mizukami; Toshio Fujioka
Journal:  J Gastroenterol       Date:  2011-12-06       Impact factor: 7.527

3.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 4.  Helicobacter pylori infection and gastric carcinoma.

Authors:  F Mégraud; E Bessède; C Varon
Journal:  Clin Microbiol Infect       Date:  2015-06-15       Impact factor: 8.067

5.  The 5300-year-old Helicobacter pylori genome of the Iceman.

Authors:  Frank Maixner; Ben Krause-Kyora; Dmitrij Turaev; Alexander Herbig; Michael R Hoopmann; Janice L Hallows; Ulrike Kusebauch; Eduard Egarter Vigl; Peter Malfertheiner; Francis Megraud; Niall O'Sullivan; Giovanna Cipollini; Valentina Coia; Marco Samadelli; Lars Engstrand; Bodo Linz; Robert L Moritz; Rudolf Grimm; Johannes Krause; Almut Nebel; Yoshan Moodley; Thomas Rattei; Albert Zink
Journal:  Science       Date:  2016-01-08       Impact factor: 47.728

6.  Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.

Authors:  Eva Doorakkers; Jesper Lagergren; Lars Engstrand; Nele Brusselaers
Journal:  Gut       Date:  2018-01-30       Impact factor: 23.059

7.  Traditional risk factors for Helicobacter pylori infection not found among patients undergoing diagnostic upper endoscopy-Republic of Georgia, 2007-2008.

Authors:  Nato Tarkhashvili; Neli Chakvetadze; Nana Mebonia; Marina Chubinidze; Lela Bakanidze; Vladimer Shengelidze; Merab Mirtskhulava; Tamar Chachava; Guram Katsitadze; Ucha Gabunia; Dimitri Kordzaia; Paata Imnadze; Jeannette Guarner; Jeremy Sobel
Journal:  Int J Infect Dis       Date:  2012-08-04       Impact factor: 3.623

8.  Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years.

Authors:  Y-J Hwang; N Kim; H S Lee; J B Lee; Y J Choi; H Yoon; C M Shin; Y S Park; D H Lee
Journal:  Aliment Pharmacol Ther       Date:  2017-11-29       Impact factor: 8.171

Review 9.  Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.

Authors:  Evariste Tshibangu-Kabamba; Yoshio Yamaoka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-17       Impact factor: 46.802

10.  Living Conditions and Helicobacter pylori in Adults.

Authors:  Odete Amaral; Isabel Fernandes; Nélio Veiga; Carlos Pereira; Claudia Chaves; Paula Nelas; Daniel Silva
Journal:  Biomed Res Int       Date:  2017-10-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.